Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Modulating bacterial cell metabolism to enhance the efficacy of antibiotics
EF 2017-18
Résumé
Antibiotics kill bacteria by poisoning their cellular machines, which perform essential functions like copying DNA, making proteins, or building a cell envelope. Bacteria can survive antibiotic treatment by (a) mutating the drug target so that the antibiotic cannot stick to it, (b) degrading the antibiotic so that it is not active, or (c) pumping the drug out of the cell. However, less well appreciated are the cases where bacteria survive antibiotic treatment by simply going to sleep and turning off their machinery. These cells, called bacterial persisters, become inactive until the antibiotic goes away, and then they start growing again - it's an ingenious trick to avoid being killed when bacteria do not have antibiotic resistance genes. Worryingly, we have recently come to find that bacteria often become persisters on the road to full-blown antibiotic resistance, highlighting the importance of figuring out how to kill these sleeping cells before it's too late. But how do you kill bacteria that aren't doing anything? You wake them up!
Here, I propose to use state-of-the-art technologies to develop ways to jump-start bacterial cell metabolism to sensitize bacteria to antibiotics. To do this, I am first going to understand precisely what components of cell metabolism are required to fully activate different antibiotic targets. Once this is complete, I am going to take both growing bacteria and persisters, and treat them with antibiotics in combination with the necessary metabolites (cellular food) to maximally activate specific parts of the cell, such that the antibiotic can efficiently kill bacteria regardless of their sleepiness. Through this research, I aim to increase the utility of our most precious antibiotics to treat infections, as well as take advantage of the diverse metabolism of different bacteria to make species-specific antibiotic therapies capable of killing bad bacteria while keeping our good bacteria happy.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
373749
Name
Stokes Jonathan M
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Modulating bacterial cell metabolism to enhance the efficacy of antibiotics
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Antibiotic Combination Therapy; Antibiotic Tolerance And Resistance; Functional Genomics; Metabolomics; Transcriptomics; Translatomics
Abstract
Antibiotics kill bacteria by poisoning their cellular machines, which perform essential functions like copying DNA, making proteins, or building a cell envelope. Bacteria can survive antibiotic treatment by (a) mutating the drug target so that the antibiotic cannot stick to it, (b) degrading the antibiotic so that it is not active, or (c) pumping the drug out of the cell. However, less well appreciated are the cases where bacteria survive antibiotic treatment by simply going to sleep and turning off their machinery. These cells, called bacterial persisters, become inactive until the antibiotic goes away, and then they start growing again - it's an ingenious trick to avoid being killed when bacteria do not have antibiotic resistance genes. Worryingly, we have recently come to find that bacteria often become persisters on the road to full-blown antibiotic resistance, highlighting the importance of figuring out how to kill these sleeping cells before it's too late. But how do you kill bacteria that aren't doing anything? You wake them up!
Here, I propose to use state-of-the-art technologies to develop ways to jump-start bacterial cell metabolism to sensitize bacteria to antibiotics. To do this, I am first going to understand precisely what components of cell metabolism are required to fully activate different antibiotic targets. Once this is complete, I am going to take both growing bacteria and persisters, and treat them with antibiotics in combination with the necessary metabolites (cellular food) to maximally activate specific parts of the cell, such that the antibiotic can efficiently kill bacteria regardless of their sleepiness. Through this research, I aim to increase the utility of our most precious antibiotics to treat infections, as well as take advantage of the diverse metabolism of different bacteria to make species-specific antibiotic therapies capable of killing bad bacteria while keeping our good bacteria happy.
Competitiondate
201709
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Stokes, Jonathan M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~